Catheters Market By Product Type (Cardiovascular Catheters, Neurovascular Catheters, Urological Catheters, Intravenous Catheters, Specialty Catheters): Global Opportunity Analysis and Industry Forecast, 2021-2031

Catheters are thin tubes made up of medical grade material such as plastic, silicon rubber, PVC, and nylon inserted in the patient’s body for therapeutic and diagnostic purposes. Catheterization is a primary co-procedure along with varied other medical procedures, such as angioplasty, cardiac electrophysiology, and neurosurgery. Catheters are important components in several surgical procedures.

High prevalence of cardiovascular diseases coupled with the development of unique-feature enhanced cardiovascular catheters is the core factor that drives the growth of the catheters market. Increase in prevalence of urological diseases, including urinary bladder cancer and kidney failure has significantly uplifted the demand for urological catheters. In addition, novel products,  including external male catheters have proved to be a lucrative addition to the overall catheters and variants’ product lines for the catheters manufacturing companies. Increase in patient pool for ischemic and hemorrhagic stroke thereby increased the demand for minimally invasive neurovascular surgeries, thus making way for opportunities for the neurovascular catheters—micro catheters and guiding catheters. Increase in cardiovascular diseases and growth in demand for minimal invasive surgeries drive the growth of global catheters market. In addition, rise in incidence of diabetes, cardiovascular diseases, urinary bladder, and kidney failures fuel the market growth. However, inadequate quality assurance and price competition at domestic levels are expected to hamper the market growth. In addition, the key players such as Boston Scientific Corporation, Medtronic Plc. and Teleflex Incorporated provide catheter products contributing toward the market growth. In addition, rise in demand for catheters for the drug administration act a key driving factor for expansion of the global market.

The global catheters market is segmented on the basis of type and region. Depending on the type, the market is segmented into cardiovascular catheters, neurovascular catheters, urological catheters, intravenous catheters and specialty catheters. 

Cardiovascular catheter segment is classified into electrophysiology catheters, percutaneous transluminal coronary angioplasty(PTCA) balloon catheters, intravascular ultrasound(IVUS catheters), percutaneous transluminal angioplasty(PTA) catheters, and others including guiding catheter, angiography catheter, and pulmonary artery catheters. In addition, urological catheter segment is  again fragmented into dialysis catheter and urinary catheter. Dialysis catheter segment is segregated into hemodialysis catheter and  peritoneal catheter. Urinary catheter segment is  segmented into and foley catheter, intermittent catheter, and external catheters.  Furthermore, intravenous catheter segment is categorized into central intravenous catheter and peripheral intravenous catheters. Peripheral intravenous catheter segment is divided into integrated catheters and short catheters. Moreover, specialty catheter segment in classified into wound/surgical drain, oximetry, thermodilution, and IUI catheter. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in the catheters market include Abbott Laboratories, Becton Dickinson And Company, Boston Scientific Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Johnson & Johnson, Medtronic, Inc., Edwards Lifesciences Corporation, Cook Medical, and Stryker Corporation.

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the catheters market analysis from 2021 to 2031 to identify the prevailing catheters market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the catheters market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global catheters market trends, key players, market segments, application areas, and market growth strategies.

By Product Type

● Cardiovascular Catheters

● Neurovascular Catheters

● Urological Catheters

● Intravenous Catheters

● Specialty Catheters

By Region

● North America

○ U.S.

○ Canada

○ Mexico

● Europe

○ Germany

○ France

○ U.K.

○ Italy

○ Spain

○ Rest of Europe

● Asia-Pacific

○ Japan

○ China

○ India

○ Australia

○ South Korea

○ Rest of Asia-Pacific

● LAMEA

○ Brazil

○ Saudi Arabia

○ South Africa

○ Rest of LAMEA

● Key Market Players

○ Abbott Laboratories

○ B. Braun Melsungen AG

○ Becton, Dickinson and Company

○ Boston Scientific Corporation

○ Johnson and Johnson

○ Medtronic Plc

○ Edwards Lifesciences Corporation

○ Teleflex Incorporated

○ Cook Medical Inc.

○ Stryker Corporatio

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Cardiovascular Catheters

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.3 Neurovascular Catheters

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Urological Catheters

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

4.5 Intravenous Catheters

4.5.1 Key market trends, growth factors and opportunities

4.5.2 Market size and forecast, by region

4.5.3 Market analysis by country

4.6 Specialty Catheters

4.6.1 Key market trends, growth factors and opportunities

4.6.2 Market size and forecast, by region

4.6.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 North America

5.2.1 Key trends and opportunities

5.2.2 North America Market size and forecast, by Product Type

5.2.3 North America Market size and forecast, by country

5.2.3.1 U.S.

5.2.3.1.1 Market size and forecast, by Product Type

5.2.3.2 Canada

5.2.3.2.1 Market size and forecast, by Product Type

5.2.3.3 Mexico

5.2.3.3.1 Market size and forecast, by Product Type

5.3 Europe

5.3.1 Key trends and opportunities

5.3.2 Europe Market size and forecast, by Product Type

5.3.3 Europe Market size and forecast, by country

5.3.3.1 Germany

5.3.3.1.1 Market size and forecast, by Product Type

5.3.3.2 France

5.3.3.2.1 Market size and forecast, by Product Type

5.3.3.3 U.K.

5.3.3.3.1 Market size and forecast, by Product Type

5.3.3.4 Italy

5.3.3.4.1 Market size and forecast, by Product Type

5.3.3.5 Spain

5.3.3.5.1 Market size and forecast, by Product Type

5.3.3.6 Rest of Europe

5.3.3.6.1 Market size and forecast, by Product Type

5.4 Asia-Pacific

5.4.1 Key trends and opportunities

5.4.2 Asia-Pacific Market size and forecast, by Product Type

5.4.3 Asia-Pacific Market size and forecast, by country

5.4.3.1 Japan

5.4.3.1.1 Market size and forecast, by Product Type

5.4.3.2 China

5.4.3.2.1 Market size and forecast, by Product Type

5.4.3.3 India

5.4.3.3.1 Market size and forecast, by Product Type

5.4.3.4 Australia

5.4.3.4.1 Market size and forecast, by Product Type

5.4.3.5 South Korea

5.4.3.5.1 Market size and forecast, by Product Type

5.4.3.6 Rest of Asia-Pacific

5.4.3.6.1 Market size and forecast, by Product Type

5.5 LAMEA

5.5.1 Key trends and opportunities

5.5.2 LAMEA Market size and forecast, by Product Type

5.5.3 LAMEA Market size and forecast, by country

5.5.3.1 Brazil

5.5.3.1.1 Market size and forecast, by Product Type

5.5.3.2 Saudi Arabia

5.5.3.2.1 Market size and forecast, by Product Type

5.5.3.3 South Africa

5.5.3.3.1 Market size and forecast, by Product Type

5.5.3.4 Rest of LAMEA

5.5.3.4.1 Market size and forecast, by Product Type

6.1. Introduction

6.2. Top winning strategies

6.3. Product Mapping of Top 10 Player

6.4. Competitive Dashboard

6.5. Competitive Heatmap

6.6. Key developments

7.1 Abbott Laboratories

7.1.1 Company overview

7.1.2 Company snapshot

7.1.3 Operating business segments

7.1.4 Product portfolio

7.1.5 Business performance

7.1.6 Key strategic moves and developments

7.2 B. Braun Melsungen AG

7.2.1 Company overview

7.2.2 Company snapshot

7.2.3 Operating business segments

7.2.4 Product portfolio

7.2.5 Business performance

7.2.6 Key strategic moves and developments

7.3 Becton, Dickinson and Company

7.3.1 Company overview

7.3.2 Company snapshot

7.3.3 Operating business segments

7.3.4 Product portfolio

7.3.5 Business performance

7.3.6 Key strategic moves and developments

7.4 Boston Scientific Corporation

7.4.1 Company overview

7.4.2 Company snapshot

7.4.3 Operating business segments

7.4.4 Product portfolio

7.4.5 Business performance

7.4.6 Key strategic moves and developments

7.5 Johnson and Johnson

7.5.1 Company overview

7.5.2 Company snapshot

7.5.3 Operating business segments

7.5.4 Product portfolio

7.5.5 Business performance

7.5.6 Key strategic moves and developments

7.6 Medtronic Plc

7.6.1 Company overview

7.6.2 Company snapshot

7.6.3 Operating business segments

7.6.4 Product portfolio

7.6.5 Business performance

7.6.6 Key strategic moves and developments

7.7 Edwards Lifesciences Corporation

7.7.1 Company overview

7.7.2 Company snapshot

7.7.3 Operating business segments

7.7.4 Product portfolio

7.7.5 Business performance

7.7.6 Key strategic moves and developments

7.8 Teleflex Incorporated

7.8.1 Company overview

7.8.2 Company snapshot

7.8.3 Operating business segments

7.8.4 Product portfolio

7.8.5 Business performance

7.8.6 Key strategic moves and developments

7.9 Cook Medical Inc.

7.9.1 Company overview

7.9.2 Company snapshot

7.9.3 Operating business segments

7.9.4 Product portfolio

7.9.5 Business performance

7.9.6 Key strategic moves and developments

7.10 Stryker Corporation

7.10.1 Company overview

7.10.2 Company snapshot

7.10.3 Operating business segments

7.10.4 Product portfolio

7.10.5 Business performance

7.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 2. CATHETERS MARKET REVENUE, FOR CARDIOVASCULAR CATHETERS, BY REGION , 2021-2031,($MILLION)

TABLE 3. CATHETERS MARKET FOR CARDIOVASCULAR CATHETERS BY COUNTRY, 2021-2031,($MILLION)

TABLE 4. CATHETERS MARKET REVENUE, FOR NEUROVASCULAR CATHETERS, BY REGION , 2021-2031,($MILLION)

TABLE 5. CATHETERS MARKET FOR NEUROVASCULAR CATHETERS BY COUNTRY, 2021-2031,($MILLION)

TABLE 6. CATHETERS MARKET REVENUE, FOR UROLOGICAL CATHETERS, BY REGION , 2021-2031,($MILLION)

TABLE 7. CATHETERS MARKET FOR UROLOGICAL CATHETERS BY COUNTRY, 2021-2031,($MILLION)

TABLE 8. CATHETERS MARKET REVENUE, FOR INTRAVENOUS CATHETERS, BY REGION , 2021-2031,($MILLION)

TABLE 9. CATHETERS MARKET FOR INTRAVENOUS CATHETERS BY COUNTRY, 2021-2031,($MILLION)

TABLE 10. CATHETERS MARKET REVENUE, FOR SPECIALTY CATHETERS, BY REGION , 2021-2031,($MILLION)

TABLE 11. CATHETERS MARKET FOR SPECIALTY CATHETERS BY COUNTRY, 2021-2031,($MILLION)

TABLE 12. CATHETERS MARKET, BY REGION, 2021-2031,($MILLION)

TABLE 13. NORTH AMERICA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 14. NORTH AMERICA CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)

TABLE 15. U.S. CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 16. CANADA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 17. MEXICO CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 18. EUROPE CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 19. EUROPE CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)

TABLE 20. GERMANY CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 21. FRANCE CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 22. U.K. CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 23. ITALY CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 24. SPAIN CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 25. REST OF EUROPE CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 26. ASIA-PACIFIC CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 27. ASIA-PACIFIC CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)

TABLE 28. JAPAN CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 29. CHINA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 30. INDIA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 31. AUSTRALIA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 32. SOUTH KOREA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 33. REST OF ASIA-PACIFIC CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 34. LAMEA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 35. LAMEA CATHETERS MARKET, BY COUNTRY, 2021-2031,($MILLION)

TABLE 36. BRAZIL CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 37. SAUDI ARABIA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 38. SOUTH AFRICA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 39. REST OF LAMEA CATHETERS MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)

TABLE 40.ABBOTT LABORATORIES: COMPANY SNAPSHOT

TABLE 41.ABBOTT LABORATORIES: OPERATING SEGMENTS

TABLE 42.ABBOTT LABORATORIES: PRODUCT PORTFOLIO

TABLE 43.ABBOTT LABORATORIES: NET SALES,

TABLE 44.ABBOTT LABORATORIES: KEY STRATERGIES

TABLE 45.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT

TABLE 46.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS

TABLE 47.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO

TABLE 48.B. BRAUN MELSUNGEN AG: NET SALES,

TABLE 49.B. BRAUN MELSUNGEN AG: KEY STRATERGIES

TABLE 50.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT

TABLE 51.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS

TABLE 52.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO

TABLE 53.BECTON, DICKINSON AND COMPANY: NET SALES,

TABLE 54.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES

TABLE 55.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT

TABLE 56.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS

TABLE 57.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO

TABLE 58.BOSTON SCIENTIFIC CORPORATION: NET SALES,

TABLE 59.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES

TABLE 60.JOHNSON AND JOHNSON: COMPANY SNAPSHOT

TABLE 61.JOHNSON AND JOHNSON: OPERATING SEGMENTS

TABLE 62.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO

TABLE 63.JOHNSON AND JOHNSON: NET SALES,

TABLE 64.JOHNSON AND JOHNSON: KEY STRATERGIES

TABLE 65.MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 66.MEDTRONIC PLC: OPERATING SEGMENTS

TABLE 67.MEDTRONIC PLC: PRODUCT PORTFOLIO

TABLE 68.MEDTRONIC PLC: NET SALES,

TABLE 69.MEDTRONIC PLC: KEY STRATERGIES

TABLE 70.EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT

TABLE 71.EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS

TABLE 72.EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO

TABLE 73.EDWARDS LIFESCIENCES CORPORATION: NET SALES,

TABLE 74.EDWARDS LIFESCIENCES CORPORATION: KEY STRATERGIES

TABLE 75.TELEFLEX INCORPORATED: COMPANY SNAPSHOT

TABLE 76.TELEFLEX INCORPORATED: OPERATING SEGMENTS

TABLE 77.TELEFLEX INCORPORATED: PRODUCT PORTFOLIO

TABLE 78.TELEFLEX INCORPORATED: NET SALES,

TABLE 79.TELEFLEX INCORPORATED: KEY STRATERGIES

TABLE 80.COOK MEDICAL INC.: COMPANY SNAPSHOT

TABLE 81.COOK MEDICAL INC.: OPERATING SEGMENTS

TABLE 82.COOK MEDICAL INC.: PRODUCT PORTFOLIO

TABLE 83.COOK MEDICAL INC.: NET SALES,

TABLE 84.COOK MEDICAL INC.: KEY STRATERGIES

TABLE 85.STRYKER CORPORATION: COMPANY SNAPSHOT

TABLE 86.STRYKER CORPORATION: OPERATING SEGMENTS

TABLE 87.STRYKER CORPORATION: PRODUCT PORTFOLIO

TABLE 88.STRYKER CORPORATION: NET SALES,

TABLE 89.STRYKER CORPORATION: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.CATHETERS MARKET SEGMENTATION

FIGURE 2.CATHETERS MARKET,2021-2031

FIGURE 3.CATHETERS MARKET,2021-2031

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.CATHETERS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.CATHETERS MARKET,BY PRODUCT TYPE,2021(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CARDIOVASCULAR CATHETERS CATHETERS MARKET,2021-2031(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF NEUROVASCULAR CATHETERS CATHETERS MARKET,2021-2031(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF UROLOGICAL CATHETERS CATHETERS MARKET,2021-2031(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF INTRAVENOUS CATHETERS CATHETERS MARKET,2021-2031(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF SPECIALTY CATHETERS CATHETERS MARKET,2021-2031(%)

FIGURE 18.CATHETERS MARKET BY REGION,2021

FIGURE 19.U.S. CATHETERS MARKET,2021-2031($MILLION)

FIGURE 20.CANADA CATHETERS MARKET,2021-2031($MILLION)

FIGURE 21.MEXICO CATHETERS MARKET,2021-2031($MILLION)

FIGURE 22.GERMANY CATHETERS MARKET,2021-2031($MILLION)

FIGURE 23.FRANCE CATHETERS MARKET,2021-2031($MILLION)

FIGURE 24.U.K. CATHETERS MARKET,2021-2031($MILLION)

FIGURE 25.ITALY CATHETERS MARKET,2021-2031($MILLION)

FIGURE 26.SPAIN CATHETERS MARKET,2021-2031($MILLION)

FIGURE 27.REST OF EUROPE CATHETERS MARKET,2021-2031($MILLION)

FIGURE 28.JAPAN CATHETERS MARKET,2021-2031($MILLION)

FIGURE 29.CHINA CATHETERS MARKET,2021-2031($MILLION)

FIGURE 30.INDIA CATHETERS MARKET,2021-2031($MILLION)

FIGURE 31.AUSTRALIA CATHETERS MARKET,2021-2031($MILLION)

FIGURE 32.SOUTH KOREA CATHETERS MARKET,2021-2031($MILLION)

FIGURE 33.REST OF ASIA-PACIFIC CATHETERS MARKET,2021-2031($MILLION)

FIGURE 34.BRAZIL CATHETERS MARKET,2021-2031($MILLION)

FIGURE 35.SAUDI ARABIA CATHETERS MARKET,2021-2031($MILLION)

FIGURE 36.SOUTH AFRICA CATHETERS MARKET,2021-2031($MILLION)

FIGURE 37.REST OF LAMEA CATHETERS MARKET,2021-2031($MILLION)

FIGURE 38. TOP WINNING STRATEGIES, BY YEAR

FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 41.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 42.COMPETITIVE DASHBOARD

FIGURE 43.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 44.ABBOTT LABORATORIES.: NET SALES ,($MILLION)

FIGURE 45.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)

FIGURE 46.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)

FIGURE 47.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)

FIGURE 48.JOHNSON AND JOHNSON.: NET SALES ,($MILLION)

FIGURE 49.MEDTRONIC PLC.: NET SALES ,($MILLION)

FIGURE 50.EDWARDS LIFESCIENCES CORPORATION.: NET SALES ,($MILLION)

FIGURE 51.TELEFLEX INCORPORATED.: NET SALES ,($MILLION)

FIGURE 52.COOK MEDICAL INC..: NET SALES ,($MILLION)

FIGURE 53.STRYKER CORPORATION.: NET SALES ,($MILLION